Magnesium sulfate for cerebral palsy prevention

Dwight J. Rouse, Karen Gibbins

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Magnesium sulfate (MgSO4) has been shown to prevent cerebral palsy among children born to women at high risk of early preterm delivery. Three large, randomized placebo-controlled trials and a subsequent Cochrane Review suggest this intervention can decrease rates of cerebral palsy by 32% with a number needed to treat of 63 to prevent one case. Not only is MgSO4 familiar to obstetricians, it also has an excellent safety profile. Simple protocols exist to help guide clinicians in using MgSO4 for this indication. Evaluation of actual clinical practice shows that this use is both feasible and can be accomplished parsimoniously.

Original languageEnglish (US)
Pages (from-to)414-416
Number of pages3
JournalSeminars in Perinatology
Volume37
Issue number6
DOIs
StatePublished - Dec 1 2013
Externally publishedYes

Fingerprint

Magnesium Sulfate
Cerebral Palsy
Numbers Needed To Treat
Randomized Controlled Trials
Placebos
Safety

Keywords

  • Cerebral palsy
  • Magnesium sulfate
  • PPROM
  • Preterm birth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Magnesium sulfate for cerebral palsy prevention. / Rouse, Dwight J.; Gibbins, Karen.

In: Seminars in Perinatology, Vol. 37, No. 6, 01.12.2013, p. 414-416.

Research output: Contribution to journalReview article

Rouse, Dwight J. ; Gibbins, Karen. / Magnesium sulfate for cerebral palsy prevention. In: Seminars in Perinatology. 2013 ; Vol. 37, No. 6. pp. 414-416.
@article{768945d7f8544dbb927fd62c82ccf07f,
title = "Magnesium sulfate for cerebral palsy prevention",
abstract = "Magnesium sulfate (MgSO4) has been shown to prevent cerebral palsy among children born to women at high risk of early preterm delivery. Three large, randomized placebo-controlled trials and a subsequent Cochrane Review suggest this intervention can decrease rates of cerebral palsy by 32{\%} with a number needed to treat of 63 to prevent one case. Not only is MgSO4 familiar to obstetricians, it also has an excellent safety profile. Simple protocols exist to help guide clinicians in using MgSO4 for this indication. Evaluation of actual clinical practice shows that this use is both feasible and can be accomplished parsimoniously.",
keywords = "Cerebral palsy, Magnesium sulfate, PPROM, Preterm birth",
author = "Rouse, {Dwight J.} and Karen Gibbins",
year = "2013",
month = "12",
day = "1",
doi = "10.1053/j.semperi.2013.06.025",
language = "English (US)",
volume = "37",
pages = "414--416",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Magnesium sulfate for cerebral palsy prevention

AU - Rouse, Dwight J.

AU - Gibbins, Karen

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Magnesium sulfate (MgSO4) has been shown to prevent cerebral palsy among children born to women at high risk of early preterm delivery. Three large, randomized placebo-controlled trials and a subsequent Cochrane Review suggest this intervention can decrease rates of cerebral palsy by 32% with a number needed to treat of 63 to prevent one case. Not only is MgSO4 familiar to obstetricians, it also has an excellent safety profile. Simple protocols exist to help guide clinicians in using MgSO4 for this indication. Evaluation of actual clinical practice shows that this use is both feasible and can be accomplished parsimoniously.

AB - Magnesium sulfate (MgSO4) has been shown to prevent cerebral palsy among children born to women at high risk of early preterm delivery. Three large, randomized placebo-controlled trials and a subsequent Cochrane Review suggest this intervention can decrease rates of cerebral palsy by 32% with a number needed to treat of 63 to prevent one case. Not only is MgSO4 familiar to obstetricians, it also has an excellent safety profile. Simple protocols exist to help guide clinicians in using MgSO4 for this indication. Evaluation of actual clinical practice shows that this use is both feasible and can be accomplished parsimoniously.

KW - Cerebral palsy

KW - Magnesium sulfate

KW - PPROM

KW - Preterm birth

UR - http://www.scopus.com/inward/record.url?scp=84888416973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888416973&partnerID=8YFLogxK

U2 - 10.1053/j.semperi.2013.06.025

DO - 10.1053/j.semperi.2013.06.025

M3 - Review article

C2 - 24290398

AN - SCOPUS:84888416973

VL - 37

SP - 414

EP - 416

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

IS - 6

ER -